PNASDisproportionality analysis to investigate fatal adverse events with immune checkpoint inhibitors: Proceed with extreme cautionBruno RevolCharles KhouriEmanuel Raschi2026-09-08Full textDOI https://doi.org/10.1073/pnas.2608648123